Haute-Normandie And NotO. Boyer
List of bibliographic references
Number of relevant bibliographic references: 10.Ident. | Authors (with country if any) | Title |
---|---|---|
000B28 | Abrar-Ahmad Zulfiqar [France] ; Rizwan Niazi [France] ; Jean-Loup Pennaforte [France] ; Emmanuel Andres [France] | Late-onset rheumatoid arthritis: clinical, biological, and therapeutic features About a retrospective study. |
000E47 | Jacques-Eric Gottenberg [France] ; Jacques Morel [France] ; Elodie Perrodeau [France] ; Thomas Bardin [France] ; Bernard Combe [France] ; Maxime Dougados [France] ; Rene-Marc Flipo [France] ; Alain Saraux [France] ; Thierry Schaeverbeke [France] ; Jean Sibilia [France] ; Martin Soubrier [France] ; Olivier Vittecoq [France] ; Gabriel Baron [France] ; Arnaud Constantin [France] ; Philippe Ravaud [France] ; Xavier Mariette [France] | Comparative effectiveness of rituximab, abatacept, and tocilizumab in adults with rheumatoid arthritis and inadequate response to TNF inhibitors: prospective cohort study |
001136 | Mathilde Leclercq [France] ; M. Le Besnerais [France] ; V. Langlois [France] ; N. Girszyn [France] ; Y. Benhamou [France] ; C. Ngo [France] ; H. Levesque [France] ; M. Muraine [France] ; J. Gueudry [France] | Tocilizumab for the treatment of birdshot uveitis that failed interferon alpha and anti-tumor necrosis factor-alpha therapy: two cases report and literature review. |
001718 | C. Derambure [France] ; G. Dzangue-Tchoupou [France] ; C. Berard [France] ; N. Vergne [France] ; M. Hiron [France] ; M. A. D Gostino [France] ; P. Musette [France] ; O. Vittecoq [France] ; T. Lequerré [France] | Pre-silencing of genes involved in the electron transport chain (ETC) pathway is associated with responsiveness to abatacept in rheumatoid arthritis |
001F46 | Rachel Audo [France] ; Claire Daien [France] ; Laura Papon [France] ; Cédric Lukas [France] ; Olivier Vittecoq [France] ; Michael Hahne [France, Pays-Bas] ; Bernard Combe [France] ; Jacques Morel [France] | Osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand as prognostic factors in rheumatoid arthritis: results from the ESPOIR cohort |
002724 | Christopher Banse [France] ; Olivier Vittecoq ; Ygal Benhamou ; Maud Gauthier-Prieur ; Thierry Lequerré ; Hervé Lévesque | Reactive macrophage activation syndrome possibly triggered by canakinumab in a patient with adult-onset Still's disease. |
002A05 | A. Frazier-Mironer [France] ; A. Cantagrel [France] ; B. Combe [France] ; V. Deschamps ; M. Dougados [France] ; R.-M. Flipo ; I. Logeart ; X. Mariette ; T. Schaeverbeke ; J. Sibilia [France] ; X. Le Loët [France] | THU0173 Retention Rates of Adalimumab, Etanercept and Infliximab as First and Second-Line Biologic Therapy in Patients with Rheumatoid Arthritis in Daily Practice: The Maintain Study |
003372 | Christopher Banse [France] ; Olivier Vittecoq [France] ; Ygal Benhamou [France] ; Maud Gauthier-Prieur [France] ; Thierry Lequerre [France] ; Hervé Levesque [France] | Un cas de syndrome d'activation macrophagique possiblement activé par le canakinumab dans le cadre d'une maladie de Still |
003560 | J E Gottenberg [France] ; P. Ravaud [France] ; A. Cantagrel [France] ; B. Combe [France] ; R M Flipo [France] ; T. Schaeverbeke [France] ; E. Houvenagel [France] ; P. Gaudin [France] ; D. Loeuille [France] ; S. Rist [France] ; M. Dougados [France] ; J. Sibilia [France] ; X. Le Loët [France] ; C. Marcelli [France] ; T. Bardin [France] ; I. Pane [France] ; G. Baron [France] ; X. Mariette [France] | Positivity for anti-cyclic citrullinated peptide is associated with a better response to abatacept: data from the ‘Orencia and Rheumatoid Arthritis’ registry |
003567 | A. Ruyssen-Witrand [France] ; S. Rouanet [France] ; B. Combe [France] ; M. Dougados [France] ; X. Le Loët [France] ; J. Sibilia [France] ; J. Tebib [France] ; X. Mariette [France] ; A. Constantin [France] | Fcγ receptor type IIIA polymorphism influences treatment outcomes in patients with rheumatoid arthritis treated with rituximab |
This area was generated with Dilib version V0.6.34. |